T1	Intervention 31 52	entecavir prophylaxis
T2	Intervention 182 203	antiviral prophylaxis
T3	Intervention 262 290	rituximab-based chemotherapy
T4	Intervention 479 771	prophylactic entecavir (ETV) before chemotherapy to 3 months after completing chemotherapy (ETV prophylactic group, n = 41) or to receive therapeutic ETV at the time of HBV reactivation and hepatitis B surface antigen (HBsAg) reverse seroconversion since chemotherapy (control group, n = 39).
T5	Intervention 977 980	ETV
T6	Intervention 1848 1869	Antiviral prophylaxis
